PROC Intrinsic Valuation and Fundamental Analysis - Procaps Group SA - Alpha Spread

Procaps Group SA
NASDAQ:PROC

Watchlist Manager
Procaps Group SA Logo
Procaps Group SA
NASDAQ:PROC
Watchlist
Price: 2.1612 USD -3.52% Market Closed
Market Cap: 243.8m USD
Have any thoughts about
Procaps Group SA?
Write Note

Intrinsic Value

PROC's intrinsic value estimate is unreliable because it is based only on its DCF value and doesn't use a relative valuation using multiples.

The intrinsic value of one PROC stock under the Base Case scenario is 4.3594 USD. Compared to the current market price of 2.1612 USD, Procaps Group SA is Undervalued by 50%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

PROC Intrinsic Value
4.3594 USD
Undervaluation 50%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Procaps Group SA

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling PROC based on its intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?
How do you feel about PROC?
Bearish
Neutral
Bullish

Fundamental Analysis

Summary

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

AI Assistant
AI Assistant
Ask me anything about Procaps Group SA

Provide an overview of the primary business activities
of Procaps Group SA.

What unique competitive advantages
does Procaps Group SA hold over its rivals?

What risks and challenges
does Procaps Group SA face in the near future?

Summarize the latest earnings call
of Procaps Group SA.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Procaps Group SA.

Provide P/S
for Procaps Group SA.

Provide P/E
for Procaps Group SA.

Provide P/OCF
for Procaps Group SA.

Provide P/FCFE
for Procaps Group SA.

Provide P/B
for Procaps Group SA.

Provide EV/S
for Procaps Group SA.

Provide EV/GP
for Procaps Group SA.

Provide EV/EBITDA
for Procaps Group SA.

Provide EV/EBIT
for Procaps Group SA.

Provide EV/OCF
for Procaps Group SA.

Provide EV/FCFF
for Procaps Group SA.

Provide EV/IC
for Procaps Group SA.

Show me price targets
for Procaps Group SA made by professional analysts.

What are the Revenue projections
for Procaps Group SA?

How accurate were the past Revenue estimates
for Procaps Group SA?

What are the Net Income projections
for Procaps Group SA?

How accurate were the past Net Income estimates
for Procaps Group SA?

What are the EPS projections
for Procaps Group SA?

How accurate were the past EPS estimates
for Procaps Group SA?

What are the EBIT projections
for Procaps Group SA?

How accurate were the past EBIT estimates
for Procaps Group SA?

Compare the revenue forecasts
for Procaps Group SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Procaps Group SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Procaps Group SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Procaps Group SA compared to its peers.

Compare the P/E ratios
of Procaps Group SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Procaps Group SA with its peers.

Analyze the financial leverage
of Procaps Group SA compared to its main competitors.

Show all profitability ratios
for Procaps Group SA.

Provide ROE
for Procaps Group SA.

Provide ROA
for Procaps Group SA.

Provide ROIC
for Procaps Group SA.

Provide ROCE
for Procaps Group SA.

Provide Gross Margin
for Procaps Group SA.

Provide Operating Margin
for Procaps Group SA.

Provide Net Margin
for Procaps Group SA.

Provide FCF Margin
for Procaps Group SA.

Show all solvency ratios
for Procaps Group SA.

Provide D/E Ratio
for Procaps Group SA.

Provide D/A Ratio
for Procaps Group SA.

Provide Interest Coverage Ratio
for Procaps Group SA.

Provide Altman Z-Score Ratio
for Procaps Group SA.

Provide Quick Ratio
for Procaps Group SA.

Provide Current Ratio
for Procaps Group SA.

Provide Cash Ratio
for Procaps Group SA.

What is the historical Revenue growth
over the last 5 years for Procaps Group SA?

What is the historical Net Income growth
over the last 5 years for Procaps Group SA?

What is the current Free Cash Flow
of Procaps Group SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Procaps Group SA.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Procaps Group SA

Balance Sheet Decomposition
Procaps Group SA

Current Assets 298.4m
Cash & Short-Term Investments 25.8m
Receivables 170.9m
Other Current Assets 101.7m
Non-Current Assets 200.2m
Long-Term Investments 6.2m
PP&E 137.4m
Intangibles 47.1m
Other Non-Current Assets 9.6m
Current Liabilities 202.9m
Accounts Payable 89.8m
Other Current Liabilities 113.2m
Non-Current Liabilities 256.2m
Long-Term Debt 220.7m
Other Non-Current Liabilities 35.6m
Efficiency

Earnings Waterfall
Procaps Group SA

Revenue
414.2m USD
Cost of Revenue
-186.2m USD
Gross Profit
228m USD
Operating Expenses
-194.2m USD
Operating Income
33.8m USD
Other Expenses
18.4m USD
Net Income
52.2m USD

Free Cash Flow Analysis
Procaps Group SA

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

Despite a challenging first half of 2023, Procaps Group is charting a path to recovery. Hindered by macroeconomic conditions such as high inflation and interest rates, Procaps faced reduced orders and rising costs. However, these are considered temporary, and the company's recovery is evident through a 4.3% revenue increase for Q2 and 7% for the first half of the year compared to the same period in the previous year. Their prescription and clinical specialties segments grew by 15% and 6% respectively, outperforming the market. New products also contributed significantly, earning $66 million and comprising 34% of total revenues. Looking ahead, aggressive cost-cutting and efficiency measures, alongside a robust product pipeline, are expected to bolster growth. Gross profit has declined due to these headwinds, yet the company is poised for a stronger Q4, indicating optimism in its long-term strategy and efforts to achieve carbon neutrality.

What is Earnings Call?
Fundamental Scores

PROC Profitability Score
Profitability Due Diligence

Procaps Group SA's profitability score is 62/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Positive Gross Profit
Exceptional ROE
Positive Net Income
62/100
Profitability
Score

Procaps Group SA's profitability score is 62/100. The higher the profitability score, the more profitable the company is.

PROC Solvency Score
Solvency Due Diligence

Procaps Group SA's solvency score is 21/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Positive Net Debt
Low Altman Z-Score
21/100
Solvency
Score

Procaps Group SA's solvency score is 21/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PROC Price Targets Summary
Procaps Group SA

Wall Street analysts forecast PROC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PROC is 5.1 USD with a low forecast of 5.05 USD and a high forecast of 5.25 USD.

Lowest
Price Target
5.05 USD
134% Upside
Average
Price Target
5.1 USD
136% Upside
Highest
Price Target
5.25 USD
143% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for PROC?

Click here to dive deeper.

Dividends

Procaps Group SA
does not pay dividends
Shareholder Yield

Current shareholder yield for PROC is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Procaps Group SA Logo
Procaps Group SA

Country

Luxembourg

Industry

Pharmaceuticals

Market Cap

243.8m USD

Dividend Yield

0%

Description

Procaps Group SA develops pharmaceutical and nutraceutical solutions, medicines, and hospital supplies. The firm develops, manufactures and sells prescription drugs and products that are differentiated by their combinations and pharmaceutical forms, as well as nutritional supplements which include omega 3 fish oils and high-potency clinical compounds. The company operates its business through 5 units which are Diabetrics, Farma Procaps, Softi Gel, Vital Care, and Clinical Specialties. Diabetrics provides diabetes solutions. Farma procaps formulates, manufactures and markets branded prescription drugs in Latin America. Softi Gel provides contract drug development and manufacturing services to third party pharmaceutical companies. Vital Care develops, manufactures and markets consumer healthcare products. Clinical Specialties develops, manufactures and markets complex drugs.

Contact

Luxembourg
9 Rue de Bitbourg
www.procapsgroup.com

IPO

2019-12-09

Employees

-

Officers

See Also

Discover More
What is the Intrinsic Value of one PROC stock?

The intrinsic value of one PROC stock under the Base Case scenario is 4.3594 USD.

Is PROC stock undervalued or overvalued?

Compared to the current market price of 2.1612 USD, Procaps Group SA is Undervalued by 50%.

Back to Top